Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
04.12.23
/
50%
€21.76
Target price
04.12.24
€26.71
Performance (%)
1.56%
End price
05.12.24
€22.10
Summary
This prediction ended on 05.12.24 with a price of €22.10. With a performance of 1.56%, the BUY prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc. closed with a slight gain. Bank_of_America_Co_ has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 7.386% | 7.386% | 307.410% |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $29.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.40
01.12.25
01.12.25
€53.46
01.12.26
01.12.26
11.35%
26.03.26
26.03.26
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€59.64
09.12.25
09.12.25
€69.55
09.12.26
09.12.26
-11.50%
26.03.26
26.03.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.47
02.01.24
02.01.24
€33.76
02.01.25
02.01.25
-33.26%
03.01.25
03.01.25